Influenza virus based Covid-19 vaccine （HuaLan）

流感病毒载体新冠肺炎疫苗（华兰）

Report date: 2022/07/01 15:15:05

Base Information

Drug NameInfluenza virus based Covid-19 vaccine （HuaLan）
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHualan Biological Bacterin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Bacterin Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A